Liu, W., Kajiyama, H., Shibata, K., Koya, Y., Senga, T., & Kikkawa, F. (2018). Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma. Oncol Lett.
Trích dẫn kiểu ChicagoLiu, Wenting, Hiroaki Kajiyama, Kiyosumi Shibata, Yoshihiro Koya, Takeshi Senga, và Fumitaka Kikkawa. "Hematopoietic Lineage Cell-specific Protein 1 Immunoreactivity Indicates an Increased Risk of Poor Overall Survival in Patients With Ovarian Carcinoma." Oncol Lett 2018.
Trích dẫn MLALiu, Wenting, et al. "Hematopoietic Lineage Cell-specific Protein 1 Immunoreactivity Indicates an Increased Risk of Poor Overall Survival in Patients With Ovarian Carcinoma." Oncol Lett 2018.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.